A wholly owned subsidiary of Lupin Limited (One of the largest pharmaceutical companies in India), Lupin Pharmaceuticals,Inc. is committed to bring specialty products, generic products, and API manufactured by Lupin Limited to the US market.
Situation
In 2003 Lupin launched its first branded drug in the US market. Suprax is a pediatric drug aimed at Otitis Media, Pharyngitis & Urinary Tract Infection. Suprax was earlier already present in the market through another Pharmaceutical company. It needed a design and advertising partner that could supplement its marketing efforts across the US, provide high quality branding solutions and quick turnaround time. At the same time offering the flexibility for Lupin to evolve its marketing needs based on the changing needs of the market and competitive forces.
Solution
Mindseye was brought in as a part of the drug launch to provide multiple design and corporate collateral design solutions. From brochure design and sales representative marketing aids to trade show booth construction, Lupin leveraged Mindseye's services for supplementing its marketing efforts. The key was to work with the existing brand identity and create a fresh compelling look that would augment the marketing strategy.
